Defining 'medical necessity' in an age of personalised medicine: A view from Canada

Timothy Caulfield1, Amy Zarzeczny

  • 1Health Law Institute, University of Alberta, Edmonton, Alberta, Canada.

Insights

Defining medical necessity in Canadian healthcare is complex, especially with personalized medicine. Physicians face challenges in defining genetically-informed medical necessity, potentially impacting cost savings.

Area of Science:

  • Health Policy
  • Genetics
  • Healthcare Systems

Background:

  • Medical necessity is crucial for healthcare funding decisions in Canada.
  • Defining and implementing medical necessity presents significant challenges.
  • Personalized medicine introduces new complexities to healthcare policy.

Purpose of the Study:

  • To explore the challenges of defining medical necessity in the context of personalized medicine.
  • To analyze the implications of genetically-informed medical necessity for healthcare policy and physician obligations.

Main Methods:

  • Conceptual analysis of medical necessity in Canadian healthcare.
  • Examination of the impact of personalized medicine on healthcare policy.
  • Discussion of physician's legal and ethical roles in defining medical necessity.

Main Results:

  • Medical necessity remains difficult to define and operationalize.
  • Personalized medicine is expected to exacerbate these definitional challenges.
  • Physicians will play a key role in defining genetically-informed medical necessity.

Conclusions:

  • The integration of personalized medicine complicates the established concept of medical necessity.
  • Physicians' obligations may limit the anticipated cost-saving benefits of personalized medicine.
  • Clearer policy frameworks are needed to address genetically-informed medical necessity.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
387
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
246